Graphical Abstract.pdf (99.03 kB)
Download fileReal-world use, safety, and patient experience of 20% subcutaneous immunoglobulin for primary immunodeficiency diseases
media
posted on 2023-09-12, 08:42 authored by Adis journalson behalf of, Maria Fasshauer, Michael Borte, Michaela Bitzenhofer, Christine Pausch, David Pittrow, Michelle Park, André Gladiator, Peter Jandus
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).